David G. Johns

14.0k citations

183 papers · 9.2k indexed · h-index 56

Impact in

Virology top 0.2%
- HIV Research and Treatment
Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 27
- HIV Research and Treatment 27
Infectious Diseases 50
- HIV/AIDS drug development and treatment 49

Co-authors: Hiroaki Mitsuya David A. Cooney Samuel Broder Neil R. Hartman Robert Yarchoan S BroderHao ZhangJan Balzarini
Journals: Biochemical Pharmacology (31 papers)Biochemical and Biophysical Research Communications (9 papers)Molecular Pharmacology (8 papers)Annals of the New York Academy of Sciences (6 papers)Journal of Clinical Investigation (6 papers)
Partner nations: United States United Kingdom France

In The Last Decade

David G. Johns

182 papers receiving 8.7k citations

Peers

Countries citing papers authored by David G. Johns

Since Specialization

Citations

This map shows the geographic impact of David G. Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Johns more than expected).

Fields of papers citing papers by David G. Johns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Johns. The network helps show where David G. Johns may publish in the future.

Co-authors

The 25 scholars most cited alongside David G. Johns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David G. Johns Line = papers co-authored together David G. Johns links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term changes in spatiotemporal distribution of Noctiluca scintillans in the southern North Sea Harmful Algae ·Eddie José Alcívar-Castro, Raúl O. Martínez‐Rincón, Burkard Baschek, Maarten Boersma, Martin Hieronymi, David G. Johns, Inga V. Kirstein, Yoana G. Voynova, Klas Ove Möller	2024	5
2	Evidence of a range expansion in sunfish from 47 years of coastal sightings Marine Biology ·Olga Lyashevska, Deirdre Brophy, Steve Wing, David G. Johns, 卓史小林, Thomas K. Doyle	2022	1
3	Increasing picocyanobacteria success in shelf waters contributes to long‐term food web degradation Global Change Biology ·Katrin Schmidt, Antony J. Birchill, Angus Atkinson, Robert J. W. Brewin, James R. Clark, Anna E. Hickman, David G. Johns, Maeve C. Lohan, Angela Milne, Silvia Pardo, Luca Polimene, Tim Smyth, Glen A. Tarran, Claire E. Widdicombe, E. Malcolm S. Woodward, Simon J. Ussher	2020	69
4	Climate- and density-dependent regulation of fish growth throughout ontogeny: North Sea sprat as a case study ICES Journal of Marine Science ·Martin Lindegren, Anna Rindorf, Tommy Norin, David G. Johns, Mikael van Deurs	2020	6
5	Understanding the Distribution of Marine Megafauna in the English Channel Region: Identifying Key Habitats for Conservation within the Busiest Seaway on Earth PLoS ONE ·Catherine McClellan, Tom Brereton, Hedyluz Araujo, David G. Johns, Wael Abdel Jaber, Samantha C. Patrick, Rod Penrose, Vincent Ridoux, Jean‐Luc Solandt, A. Kieslinger, Stephen C. Votier, Ruth Williams, Brendan J. Godley	2014	56
6	Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program Bone Marrow Transplantation ·Paul Shaughnessy, Joseph P. Uberti, Steven M. Devine, Ιωάννης Βούλγαρης, J. M. Vose, Ivana N. Micallef, Eric D. Jacobsen, John M. McCarty, Patrick J. Stiff, Andrew Artz, Edward D. Ball, R.B. Berryman, Michael J. Dugan, Robin Joyce, Frank J. Hsu, David G. Johns, Peter A. McSweeney	2012	29
7	Wasp-Waist Interactions in the North Sea Ecosystem PLoS ONE ·Per Fauchald, Henrik Skov, Mette Skern‐Mauritzen, David G. Johns, Torkild Tveraa	2011	65
8	The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects British Journal of Pharmacology ·David G. Johns, David J. Behm, Deborah J. Walker, Ao Zhang, EMANUEL, Dion A. Daniels, Qurrotu A'yun., Simon J. Dowell, 裘文文, Paul G. Green, Usman Shabon, Weike Bao, N Aiyar, Steven Quiceno Lopera, Andrew J. Brown, Alastair Morrison, Stephen A. Douglas	2007	198
9	Exceptional abundance of the snake pipefish (Entelurus aequoreus) in the north-eastern Atlantic Ocean Open MIND ·J. A. Lindley, Richard R. Kirby, David G. Johns, Philip C. Reid	2006	10
10	Biosynthetic Ganciclovir Triphosphate: Its Isolation and Characterization from Ganciclovir-Treated Herpes Simplex Thymidine Kinase-Transduced Murine Cells Biochemical and Biophysical Research Communications ·Riad Agbaria, Fabio Candotti, James A. Kelley, Hao Zhang, David G. Johns, David A. Cooney, R. Michael Blaese, Harry Ford	2001	8
11	Potentiation of The Anti-HIV Activity of Zalcitabine and Lamivudine by a CTP Synthase Inhibitor, 3-Deazauridine Nucleosides Nucleotides & Nucleic Acids ·Oleg V. Martselyak, David G. Johns, Hiroaki Mitsuya	2000	24
12	Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. Journal of Clinical Investigation ·Wen Gao, T Shirasaka, David G. Johns, S Broder, Hiroaki Mitsuya	1993	203
13	Modulation of Metabolism and Anti-HIV-1 Activity of Purine 2′,3′-Dideoxynucleosides by IMP Dehydrogenase Inhibitors Advances in experimental medicine and biology ·Abdellatif Dahi, Brian L. Robbins, Gurpreet S. Ahluwalia, Hiroaki Mitsuya, David G. Johns, Arnold Fridland	1991	3
14	Ability of Anti-HIV Agents to Inhibit HIV Replication in Monocyte/Macrophages or U937 Monocytoid Cells Under Conditions of Enhancement by GM-CSF or Anti-HIV Antibody AIDS Research and Human Retroviruses ·Carlo Federico Perno, David A. Cooney, Michael J. Currens, G Rocchi, David G. Johns, Samuel Broder, Robert Yarchoan	1990	22
15	Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV Infection AIDS Research and Human Retroviruses ·Neil R. Hartman, David G. Johns, Hiroaki Mitsuya	1990	63
16	Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2′,3′-dideoxyguanosine Biochemical and Biophysical Research Communications ·Gurpreet S. Ahluwalia, David A. Cooney, R W Spingarn, Michael J. Currens, Harry Ford, David G. Johns, Hiroaki Mitsuya, Arnold Fridland	1990	20
17	Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides. The Journal of Experimental Medicine ·Carlo Federico Perno, Robert Yarchoan, David A. Cooney, Neil R. Hartman, S Gartner, M Popovic, Hao Zhang, T L Gerrard, Yvonne A. Wilson, David G. Johns	1988	198
18	2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis. Molecular Pharmacology ·Jan Balzarini, David A. Cooney, Maha Dalal, Muhammad Nazeer, James Cupp, Erik De Clercq, S Broder, David G. Johns	1987	65
19	Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties. PubMed ·Maha Dalal, Jacqueline Plowman, Theodore R. Breitman, Hildegard M. Schuller, Michela Fraganza, David T. Vistica, John S. Driscoll, David A. Cooney, David G. Johns	1986	24
20	Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance. PubMed ·Gurpreet S. Ahluwalia, Marvin B. Cohen, Muhammad Nazeer, Susan T. Arnold, James B. McMahon, Maha Dalal, Yvonne A. Wilson, David A. Cooney, Jan Balzarini, David G. Johns	1986	17

About David G. Johns

David G. Johns is a scholar working on Virology, Infectious Diseases, Physiology, Oceanography and Global and Planetary Change, having authored 183 papers that have together received 9.2k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (50 papers), HIV/AIDS drug development and treatment (49 papers), Marine and fisheries research (28 papers), HIV Research and Treatment (27 papers), Marine and coastal ecosystems (25 papers), Marine Biology and Ecology Research (20 papers), Cytomegalovirus and herpesvirus research (19 papers) and Enzyme function and inhibition (13 papers). The work is most often cited by research in Virology (2.2k citations), Infectious Diseases (3.3k citations), Physiology (462 citations), Oceanography (922 citations) and Epidemiology (1.8k citations). David G. Johns has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Hiroaki Mitsuya, David A. Cooney, Samuel Broder, Neil R. Hartman, Robert Yarchoan, S Broder, Hao Zhang, Jan Balzarini, Bruce A. Chabner and Erik De Clercq. Their work appears in journals such as Biochemical Pharmacology, Biochemical and Biophysical Research Communications, Molecular Pharmacology, Annals of the New York Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact